SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-024656
Filing Date
2019-05-09
Accepted
2019-05-09 08:31:37
Documents
82
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv519530_10q.htm 10-Q 601373
2 EXHIBIT 10.1 tv519530_ex10-1.htm EX-10.1 20092
3 EXHIBIT 31.1 tv519530_ex31-1.htm EX-31.1 10952
4 EXHIBIT 31.2 tv519530_ex31-2.htm EX-31.2 11210
5 EXHIBIT 32.1 tv519530_ex32-1.htm EX-32.1 5602
  Complete submission text file 0001144204-19-024656.txt   9194482

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT anip-20190331.xml EX-101.INS 3036492
7 XBRL TAXONOMY EXTENSION SCHEMA anip-20190331.xsd EX-101.SCH 52153
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20190331_cal.xml EX-101.CAL 62145
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20190331_def.xml EX-101.DEF 409484
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20190331_lab.xml EX-101.LAB 400709
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20190331_pre.xml EX-101.PRE 450420
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 19808920
SIC: 2834 Pharmaceutical Preparations